The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Human Immunodeficiency Virus Type 1 Is Trapped by Acidic but Not by Neutralized Human Cervicovaginal Mucus
Open accessAbstract
To reliably infect a primate model for human immunodeficiency virus (HIV), ∼10,000-fold more virus must be delivered vaginally than intravenously. However, the vaginal mechanisms that help protect against HIV are poorly understood. Here, we report that human cervicovaginal mucus (CVM), obtained from donors with normal lactobacillus-dominated vaginal flora, efficiently traps HIV, causing it to diffuse more than 1,000-fold more slowly than it does in water. Lactobacilli acidify CVM to pH ∼4 by continuously producing lactic acid. At this acidic pH, we found that lactic acid, but not HCl, abolished the negative surface charge on HIV without lysing the virus membrane. In contrast, in CVM neutralized to pH 6 to 7, as occurs when semen temporarily neutralizes the vagina, HIV maintained its native surface charge and diffused only 15-fold more slowly than it would in water. Thus, methods that can maintain both a high lactic acid content and acidity for CVM during coitus may contribute to both vaginal and penile protection by trapping HIV before it can reach target cells. Our results reveal that CVM likely plays an important but currently unappreciated role in decreasing the rate of HIV sexual transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Self-citationBacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706 · cited 2×
“BV has been identified as an important factor in the spread of the HIV pandemic (1, 28).”
BackgroundTarget cells in vaginal HIV transmission
Miller, C. J., & Shattock, R. J. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00056-4 · Cited by 220 · cited 1×
“This efficient trapping of HIV in acidic mucus most likely reduces the fraction of HIV particles that could penetrate the acidic mucus barrier and reach target cells located in the epithelium (20, 27).”
Background
Cited by
Vaginal microbiome of reproductive-age women
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002611107 · Cited by 4,254
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Self-citationThe immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Romero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
Vaginal Microbiome: Rethinking Health and Disease
Ma, B., Forney, L. J., & Ravel, J. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092611-150157 · Cited by 729
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
(2013) · Menopause · doi:10.1097/gme.0b013e3182a122c2 · Cited by 560
The role of lactic acid production by probiotic Lactobacillus species in vaginal health
Tachedjian, G., Aldunate, M., Bradshaw, C. S., & Cone, R. A. (2017) · Research in Microbiology · doi:10.1016/j.resmic.2017.04.001 · Cited by 557
Self-citationVaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota
O’Hanlon, D. E., Moench, T. R., & Cone, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080074 · Cited by 547
Self-citation(2020) · Menopause · doi:10.1097/gme.0000000000001609 · Cited by 531
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
“Yet again, although the health benefits of vaginal lactobacilli are widely recognized, they have been poorly substantiated by molecular studies.”
BackgroundEvaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome
Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z., & Forney, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033865 · Cited by 511
“For example, bacteria in the human intestine contribute to digestion of inaccessible compounds [2] and development of the host immune system [3,4], while vaginal microbiota helps prevent urogenital diseases and maintain health in women [5,6,7].”
BackgroundBiological hydrogels as selective diffusion barriers
Lieleg, O., & Ribbeck, K. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.06.002 · Cited by 387
Aldunate, M., Srbinovski, D., Hearps, A. C., Latham, C. F., Ramsland, P. A., Gugasyan, R., Cone, R. A., & Tachedjian, G. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00164 · Cited by 387
Self-citationNanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
Self-citationMucus-Penetrating Nanoparticles for Vaginal Drug Delivery Protect Against Herpes Simplex Virus
Ensign, L. M., Tang, B. C., Wang, Y.-Y., Tse, T. A., Hoen, T., Cone, R., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003453 · Cited by 368
“Healthy CVM itself is a somewhat effective barrier to viral infections (44).”
BackgroundSelf-citationThe role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 357
Association of the Vaginal Microbiota with Human Papillomavirus Infection in a Korean Twin Cohort
Lee, J. E., Lee, S., Lee, H., Song, Y.-M., Lee, K., Han, M. J., Sung, J., & Ko, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063514 · Cited by 340
Understanding and learning from the success of prophylactic human papillomavirus vaccines
Schiller, J. T., & Lowy, D. R. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2872 · Cited by 293
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R., & Hanes, J. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 290
Self-citationMontefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis367 · Cited by 284
Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective
Brotman, R. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57172 · Cited by 283
Kalia, N., Singh, J., & Kaur, M. (2020) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-020-0347-4 · Cited by 275
Mucoadhesive and thermogelling systems for vaginal drug delivery
Caramella, C. M., Rossi, S., Ferrari, F., Bonferoni, M. C., & Sandri, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.001 · Cited by 264
Deep Sequencing of the Vaginal Microbiota of Women with HIV
Hummelen, R., Fernandes, A. D., Macklaim, J. M., Dickson, R. J., Changalucha, J., Gloor, G. B., & Reid, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012078 · Cited by 262
Cell-to-cell transmission of viruses
Zhong, P., Agosto, L. M., Munro, J. B., & Mothes, W. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.11.004 · Cited by 231
“In contrast, when viral particles decay or are trapped by extracellular factors, diffusion of infectious viral particles becomes very inefficient [33].”
BackgroundNunn, K. L., Wang, Y.-Y., Harit, D., Humphrys, M. S., Ma, B., Cone, R., Ravel, J., & Lai, S. K. (2015) · mBio · doi:10.1128/mbio.01084-15 · Cited by 194
Mucin biopolymers as broad-spectrum antiviral agents
Lieleg, O., Lieleg, C., Bloom, J., Buck, C. B., & Ribbeck, K. (2012) · Biomacromolecules · doi:10.1021/bm3001292 · Cited by 167
Polymer-based nanocarriers for vaginal drug delivery
das Neves, J., Nunes, R., Machado, A., & Sarmento, B. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.12.004 · Cited by 138
Wessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102
“…who were highly exposed to HIV-1 yet remained seronegative (Box 1), dampened genital immunity was proposed to limit target cell availability and activation, and to maintain the protective vaginal barrier, thus decreasing the risk of HIV-1 infecting its target cell population (Lajoie et al., 2012).”
The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis
Baldewijns, S., Sillen, M., Palmans, I., Vandecruys, P., Van Dijck, P., & Demuyser, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.705779 · Cited by 44
Metadata
- Authors
- Lai, S. K., Hida, K., Shukair, S., Wang, Y.-Y., Figueiredo, A., Cone, R., Hope, T. J., & Hanes, J.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2009-11
- Volume
- 83
- Issue
- 21
- Pages
- 11196-11200
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2132622748
- Cited by
- 251
- References
- 4
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.